Somatoform Disorders
29
0
1
19
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.3%
3 terminated out of 29 trials
86.4%
-0.1% vs benchmark
17%
5 trials in Phase 3/4
11%
2 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (29)
Mapping the Healthcare Pathway to Multidisciplinary Assessment of 12-25 Year Olds With Somatic Symptom Disorder
Ultra-brief Psychological Treatments for Emotional Symptoms and Disorders
Ketamine Safety and Tolerability in Psychiatric Inpatient Care (KetGD)
Build a Research Clinic for Somatoform Patients
Neurovegetative Decoupling in Somatoform Disorders : Biofeedback Interest
Cost-benefit Evaluation of a Transdiagnostic Psychological Treatment for Emotional Disorders in Primary Care
Welfare Benefits in Functional Somatic Disorders
Psychological Risk Factors for Functional Somatic Disorders
School Withdrawal in Adolescents
Brief Evidence-based Psychological Treatments for Emotional Disorders
Subjective Perception of Motor Control During Psychogenic Disorders
Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder
Acceptance and Commitment Group Therapy for Adolescents With a Range of Functional Somatic Syndromes
Treatment of Globus Sensations With Psychotherapy
Systematic Screening for Comorbid Psychological Conditions in Cardiac ACSC Patients With Multimorbidity in the ED
Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
Imipramine Treatment for Patients With Multi-organ Bodily Distress Syndrome
Acceptance and Commitment Therapy for Patients With Multi-organ Bodily Distress Syndrome (Stress-4)
Stress and Health Interview for Primary Care Patients With Medically Unexplained Symptoms
Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis